Symbiotix Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Symbiotix's estimated annual revenue is currently $21.9M per year.(i)
  • Symbiotix's estimated revenue per employee is $201,000

Employee Data

  • Symbiotix has 109 Employees.(i)
  • Symbiotix grew their employee count by -5% last year.

Symbiotix's People

NameTitleEmail/Phone
1
EVP, Creative StrategyReveal Email/Phone
2
SVP, Clinical ServicesReveal Email/Phone
3
VP, Account SupervisorReveal Email/Phone
4
VP, Account SupervisorReveal Email/Phone
5
EVP, Clinical Strategy and InnovationReveal Email/Phone
6
EVP, Management SupervisorReveal Email/Phone
7
VP, Group Account SupervisorReveal Email/Phone
8
SVP Management SupervisorReveal Email/Phone
9
Senior Medical DirectorReveal Email/Phone
10
Managing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M420%N/AN/A
#2
$970.9M30195%$47.1MN/A
#3
$1.4M70%N/AN/A
#4
$21.9M109-5%N/AN/A
#5
$12.9M6425%N/AN/A
#6
$14.7M879%N/AN/A
#7
$15.1M756%N/AN/A
#8
$109.9M54723%N/AN/A
#9
$12.3M615%N/AN/A
#10
$76.2M3790%N/AN/A
Add Company

What Is Symbiotix?

At Symbiotix, we recognize the challenges our clients face in today?s fiercely competitive and rapidly changing marketplace. As a scientific medical communications agency, we solve these challenges and help our clients break through the clutter with our proprietary strategic model, Science that Activates.? The principles of Science that Activates? are based on the foundation of adult learning where education focuses on changing Knowledge, Attitudes, and Behaviors. We take a step-by-step approach to Explore, Synthesize, Translate, and Activate the science. Our action?oriented approach combined with our scientific expertise, proven process, and integrated team structure keep us successfully grounded in the principles of Science that Activates? and allow us to deliver the right message, to the right audience at the right time. We have a multitude of scientific?medical communications services and an extensive global network to fit our clients? communications needs. We are a passionate partner; our reputation is built on producing results by elevating the science and serving as a champion of change.

keywords:N/A

N/A

Total Funding

109

Number of Employees

$21.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Symbiotix News

2022-04-20 - Human Microbiome Market Size and Precise Outlook:2022 ...

... Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC.

2022-04-17 - Global Human Microbiome Market In-depth Research Studies ...

... Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC,.

2022-04-13 - Global Microbiome Therapeutics Market 2022 Business ...

... MicroBiome Therapeutics LLC, Metabiomics, Ritter Pharmaceuticals, Symberix, OpenBiome, Azitra, Symbiotix Biotherapies, Osel, Metabogen,.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.9M10918%N/A
#2
$16.4M109-8%N/A
#3
$15M1106%N/A
#4
$7.5M1100%$30M
#5
$35M1118%N/A